| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=10uM, (2S)-4-cyclohexyl-2-[[1-[(4-nitrophenyl)methyl]-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]amino]butanoic acid, Angiotensin AT2 Antagonists targeting AGTR2 (Novartis, 22878749) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/22878749 |
| Similar Terms | |
| Downloads & Tools |
4 genes differentially expressed following the CA-17-QL18_10uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| OAZ1 | ornithine decarboxylase antizyme 1 | 0.240335 |
| Symbol | Name | Standardized Value |
|---|---|---|
| C15ORF38-AP3S2 | C15orf38-AP3S2 readthrough | -0.313316 |
| STAU1 | staufen double-stranded RNA binding protein 1 | -0.238852 |
| FXR1 | fragile X mental retardation, autosomal homolog 1 | -0.219392 |